ALIVUS — Alivus Life Sciences Share News
0.000.00%
Last trade - 00:00- IN₹153.54bn
- IN₹145.96bn
- IN₹25.52bn
Brief: Glenmark Life Sciences Q2 Profit 953.2 Mln Rupees
Brief: Glenmark Life Changes Name Of Co To "Alivus Life Sciences Limited"
Brief: Glenmark Life Says Stake Of Promoter In Co Reduced From 75.00073% To 74.99982%
India's Glenmark Life Sciences posts higher Q1 revenue on API boost
Brief: Glenmark Life Says Ankleshwar Capacity Expansion Construction Completed, To Be Operational In Q2FY25
Brief: Glenmark Life Re-Appoints Yasir Rawjee As MD, CEO
Brief: Glenmark Life Anticipates Delivering Steady Growth With Stable Margins Throughout Fy25
Brief: Glenmark Life Sciences Q1 Profit 1.11 Billion Rupees
Brief: Glenmark Life Gets Issue Of Closure Notice For Ankleshwar Facility By GPCB
Brief: Glenmark Says Entered Into Letter Agreement With Glenmark Pharmaceuticals And Nirma
India's Glenmark Pharma posts Q4 loss as stake-sale related costs weigh
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
India's Laurus Labs closes lower on fifth straight qtrly profit drop
India's Glenmark Life Sciences posts lower Q4 profit as Red Sea crisis hurts API business
India's Glenmark Life Sciences slides as Q4 profit falls
Brief: Glenmark Life Sciences March-Quarter Profit Falls
India's Laurus Labs hits near 1-1/2 year high
Brief: Glenmark Life Sciences Says Nirma Acquires Majority Stake In Co
Brief: Glenmark Life Sciences Says Glenn Saldanha Tendered His Resignation As Chairman